Sunitinib Proves Cardiotoxic in GI Tumor Treatment - in Hematology/Oncology, Other Cancers from MedPage Today

Medical News: "Treatment of gastrointestinal stromal tumors with sunitinib (Sutent) led to cardiac events in 11% of patients and to clinically relevant reductions in ejection fraction in almost 30%, investigators found."